Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Previous research from our laboratory demonstrated that administration of single doses (120, 240, 360 mg) of standardised Ginkgo biloba extract (GBE) had linear, dose‐dependent, positive effects on the speed of performing attention tasks in comparison to placebo. However, whilst the lowest dose, which is typical of a recommended daily dose, had no effect on the speed of attention task performance it did engender mild improvements in secondary memory performance. The current study presents a reanalysis of data from three methodologically identical studies that each included a treatment of 120 mg GBE and matched placebo. All three studies were of a multiple dose, placebo‐controlled, double‐blind, balanced‐crossover design, employing four or five treatment arms in total. Across the studies 78 healthy young participants received 120 mg GBE and placebo in randomly counterbalanced order, separated by a wash‐out period of at least 7 days. On each study day participants' performance on the Cognitive Drug Research (CDR) computerised cognitive assessment battery was measured immediately prior to dosing and at 1, 2.5, 4 and 6 hr following treatment, with scores collapsed into the six measures (speed of attention, accuracy of attention, secondary memory, working memory, speed of memory, quality of memory) which have previously been derived by factor analysis of the data from CDR subtests. The results showed that 120 mg of Ginkgo engendered a significant improvement on the ‘quality of memory’ factor that was most evident at 1 and 4 hr post‐dose, but had a negative effect on performance on the ‘speed of attention’ factor that was most evident at 1 and 6 hr post‐dose. The current study confirmed the previous observation of modestly improved memory performance following 120 mg of GBE, but suggests that acute administration of this typical daily dose may have a detrimental effect on the speed of attention task performance which is opposite to that seen previously following higher doses. Copyright © 2007 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of the antioxidant action of Ginkgo biloba extract (EGb 761) on aging and oxidative stress
Droy-Lefaix, M. T. (1997) · AGE · doi:10.1007/s11357-997-0013-1 · Cited by 49 · cited 1×
“For instance: scavenging and inhibition of free radicals (for reviews see: Droy-Lefaix, 1997; Ramassamy, 2006), a potential antagonism of platelet activating factor (e.g. Akiba et al., 1998; Krane et al., 2003), modulation of a number of neurotransmitter systems (e.g. Ahlemeyer Received 15 March…”
Background
Cited by
Kennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684
Self-citationAssessment of spatial memory in mice
Sharma, S., Rakoczy, S., & Brown-Borg, H. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.09.004 · Cited by 368
Multifaceted Therapeutic Benefits of Ginkgo biloba L.: Chemistry, Efficacy, Safety, and Uses
Mahadevan, S., & Park, Y. (2008) · Journal of Food Science · doi:10.1111/j.1750-3841.2007.00597.x · Cited by 351
Mental Performance and Sport: Caffeine and Co-Consumed Bioactive Ingredients
Kennedy, D. O., & Wightman, E. L. (2022) · Sports Medicine · doi:10.1007/s40279-022-01796-8 · Cited by 50
Self-citationSilberstein, R. B., Pipingas, A., Song, J., Camfield, D. A., Nathan, P. J., & Stough, C. (2011) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2011/164139 · Cited by 36
“Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2011, Article ID 164139, 10 pages doi:10.1155/2011/164139”
BackgroundInfluential
Metadata
- Authors
- Kennedy, D. O., Jackson, P. A., Haskell, C. F., & Scholey, A. B.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2007-09-28
- Volume
- 22
- Issue
- 8
- Pages
- 559-566
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W2049673277
- Cited by
- 62
- References
- 1
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.